Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism - Adial Pharmaceuticals (NASDAQ:ADIL)
CHARLOTTESVILLE, Va., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL, ADILW)) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the
United Kingdom David Waldman Alexandra Schilt Bankole Johnson Giovanni Addolorato Otto Lesch European Society For Biomedical Research On Alcoholism
Source: benzinga.com